Related Experiment Video

Updated: Jun 12, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial

Stephen R Cole1, Elizabeth A Stuart

  • 1Department of Epidemiology, Center for AIDS Research, University of North Carolina, Chapel Hill, USA. cole@unc.edu

American Journal of Epidemiology
|June 16, 2010
PubMed

Insights

This study introduces a model-based method to improve the generalizability of clinical trial results. The method standardizes human immunodeficiency virus (HIV) trial data to a target population, enhancing external validity.

Area of Science:

  • Clinical Trials & Epidemiology
  • Biostatistics
  • Public Health

Background:

  • Randomized clinical trials (RCTs) are crucial but often lack external validity.
  • Generalizability of trial findings to diverse populations remains a challenge.
  • Human immunodeficiency virus (HIV) treatment trials provide a case study for assessing external validity.

Purpose of the Study:

  • To present and validate a model-based method for standardizing RCT results to a target population.
  • To address the issue of external validity in HIV clinical trials.
  • To provide simulation evidence supporting the proposed standardization method.

Main Methods:

  • Utilized data from a 1996 HIV treatment trial comparing highly active antiretroviral therapy (HAART) with ineffective combination therapy.
  • Defined a target population of US individuals with HIV in 2006 using CDC estimates.
  • Employed Monte Carlo simulations to evaluate the method's performance under heterogeneous treatment effects.

Main Results:

  • The proposed method standardized trial results to the 2006 target population, showing a 12% muted effect.
  • Conventional intent-to-treat estimates exhibited bias and poor confidence interval coverage in simulations.
  • The novel standardization method demonstrated unbiased estimates and appropriate confidence limit coverage.

Conclusions:

  • The developed method effectively standardizes observed trial results to a specified target population.
  • This approach enhances the assessment of clinical trial generalizability.
  • The method offers improved accuracy over conventional estimates when treatment effects vary within populations.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Group Design02:01

Group Design

The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between the two are due to...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...